Swissport looks forward to strengthening its location at the forefront of pharmaceutical logistics, thanks to a network of modern drug centers, strong infrastructure, focus on innovation, compliance and sustainability.
With twenty -three centers of accredited drugs and sixty -five warehouses capable of drugs all over the world, swissport has become a reliable partner in transporting sensitive goods to temperature. The company’s facilities meet the highest international standards, including GDP (good distribution exercise), IATA CEV Pharma, and British MHRA certificate.
“What distinguishes swissport away from the quality of its infrastructure-designed for temperature-sensitive goods-but also to comply with the strict process and training programs for dealing with pharmaceutical and medical products.”
Swissport success depends on a comprehensive cold series strategy. From specific temperature areas (-20 ° C, 2-8 ° C, 15-25 ° C) to real time monitoring and specialized cooling containers, each step is designed from the process to protect the safety of the product. “Facilities are equipped with separate storage areas for each temperature range, and the advanced cooling infrastructure reduces temperature fluctuations,” he explained.
Cold and sustainable
Swissport’s Cool+Connect, a dedicated solution that has been developed in cooperation with airlines and shipping charges to reduce handling times by integrating dedicated corridors that are primarily controlled and direct access from the runway.
This process includes a 136 square meter corridor that is controlled at the temperature to directly reach the airport, cutting times, and eliminate the need for truck transport outside the site.
Benck pointed out that “improved operations maintains consistent temperature conditions throughout the handling process, ensuring that it maintains the safety of drug shipments 2-8 degrees Celsius from accessing aircraft loading.”
“In addition, the elimination of outside air transport reduces fuel consumption and associated emissions. Simplified processes and enhancing coordination between ground processes increases resource use, which leads to great cost savings.”
Swissport also runs Cooltainer warehouses to ensure the availability of active cooling containers for time charges. “This reduces the late times of urgent shipments, while the appropriate handling-using the appropriate equipment-causes damage and repairing the needs of these highly valuable containers,” said Behnke.
“With solutions like Cool+Connect, Swissport merges shipments into the airport, eliminating the need for an empty container truck for suppliers for loading. This reduces CO₂ emissions by up to 70 %, truck transport costs of up to 50 %, and provide up to 3 hours of time.”
Technological tools
Infrastructure developments support digital transformation is a major component of the Swissport strategy. Through available platforms, customers acquire a full vision in the case of charging, from actual time monitoring to evaluate the risk of corridors.
Digital tools have simplified the inspection of pharmaceutical shipments through the automation of data collection and enhance the actual time monitoring capabilities.
These technologies reduce manual errors, accelerate documents operations, and facilitate faster approvals, which improves operational efficiency. As a result, swissport can ensure that medications are dealt with according to regulatory requirements while reducing the delay in the supply chain.
“Validaide is a major part of our risk assessment of our corridors and the rehabilitation of digital suppliers. It allows our partners – manufacturers, airlines and freight preparation – by evaluating roads, storage conditions and dealing with our network processing processes. Swissport maintains Validaide’s features regularly to support decisions and enforcement (compulsing vs.
“This transparency provides more proactive decisions and adopts confidence in the integrity of the handling process-an eccentric matter for temperature sensitive products.”
The next step
Looking at the future, Swissport plans to continue to explore the improvement of AI operations, automation of warehouses, and expanded use of actual time tracking. These investments aim to improve efficiency, reduce errors and enhance vision through the entire cold chain.
“Through specialized training, practical discipline, digital integration, GHSAS like Swissport now plays an active role in risk management and the reliability of the supply chain for critical charges.”
“Swissport is investing in new pharmaceutical centers, upgrading current positions to meet the growing global demand. We also submit cooperation with stakeholders in the industry and explore new technologies to increase our display of the cold series.”
